113 related articles for article (PubMed ID: 22417826)
1. Distribution and histologic effects of intravenously administered amorphous nanosilica particles in the testes of mice.
Morishita Y; Yoshioka Y; Satoh H; Nojiri N; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Tsutsumi Y
Biochem Biophys Res Commun; 2012 Apr; 420(2):297-301. PubMed ID: 22417826
[TBL] [Abstract][Full Text] [Related]
2. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Kondoh M; Yagi K; Mayumi T; Tsunoda S; Tsutsumi Y
Nanotechnology; 2012 Feb; 23(4):045101. PubMed ID: 22214761
[TBL] [Abstract][Full Text] [Related]
3. Dermal absorption of amorphous nanosilica particles after topical exposure for three days.
Hirai T; Yoshikawa T; Nabeshi H; Yoshida T; Akase T; Yoshioka Y; Itoh N; Tsutsumi Y
Pharmazie; 2012 Aug; 67(8):742-3. PubMed ID: 22957443
[TBL] [Abstract][Full Text] [Related]
4. Suppression of nanosilica particle-induced inflammation by surface modification of the particles.
Morishige T; Yoshioka Y; Inakura H; Tanabe A; Narimatsu S; Yao X; Monobe Y; Imazawa T; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Arch Toxicol; 2012 Aug; 86(8):1297-307. PubMed ID: 22418595
[TBL] [Abstract][Full Text] [Related]
5. Surface modification of amorphous nanosilica particles suppresses nanosilica-induced cytotoxicity, ROS generation, and DNA damage in various mammalian cells.
Yoshida T; Yoshioka Y; Matsuyama K; Nakazato Y; Tochigi S; Hirai T; Kondoh S; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Tsutsumi Y
Biochem Biophys Res Commun; 2012 Nov; 427(4):748-52. PubMed ID: 23044420
[TBL] [Abstract][Full Text] [Related]
6. Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice.
Yoshida T; Yoshioka Y; Tochigi S; Hirai T; Uji M; Ichihashi K; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Higashisaka K; Yoshikawa T; Tsutsumi Y
Part Fibre Toxicol; 2013 Aug; 10():41. PubMed ID: 23958113
[TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
8. Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Matsuo K; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Nakagawa S; Mayumi T; Tsunoda S; Tsutsumi Y
Biomaterials; 2011 Apr; 32(11):2713-24. PubMed ID: 21262533
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice.
Xie G; Sun J; Zhong G; Shi L; Zhang D
Arch Toxicol; 2010 Mar; 84(3):183-90. PubMed ID: 19936708
[TBL] [Abstract][Full Text] [Related]
10. Testicular biodistribution of silica-gold nanoparticles after intramuscular injection in mice.
Leclerc L; Klein JP; Forest V; Boudard D; Martini M; Pourchez J; Blanchin MG; Cottier M
Biomed Microdevices; 2015 Aug; 17(4):66. PubMed ID: 26044201
[TBL] [Abstract][Full Text] [Related]
11. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Cho M; Cho WS; Choi M; Kim SJ; Han BS; Kim SH; Kim HO; Sheen YY; Jeong J
Toxicol Lett; 2009 Sep; 189(3):177-83. PubMed ID: 19397964
[TBL] [Abstract][Full Text] [Related]
12. Silica nanoparticles as hepatotoxicants.
Nishimori H; Kondoh M; Isoda K; Tsunoda S; Tsutsumi Y; Yagi K
Eur J Pharm Biopharm; 2009 Aug; 72(3):496-501. PubMed ID: 19232391
[TBL] [Abstract][Full Text] [Related]
13. Protein corona changes mediated by surface modification of amorphous silica nanoparticles suppress acute toxicity and activation of intrinsic coagulation cascade in mice.
Yoshida T; Yoshioka Y; Morishita Y; Aoyama M; Tochigi S; Hirai T; Tanaka K; Nagano K; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Higashisaka K; Tsutsumi Y
Nanotechnology; 2015 Jun; 26(24):245101. PubMed ID: 26011124
[TBL] [Abstract][Full Text] [Related]
14. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles.
Sayes CM; Reed KL; Glover KP; Swain KA; Ostraat ML; Donner EM; Warheit DB
Inhal Toxicol; 2010 Mar; 22(4):348-54. PubMed ID: 20001567
[TBL] [Abstract][Full Text] [Related]
15. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.
Liu T; Li L; Teng X; Huang X; Liu H; Chen D; Ren J; He J; Tang F
Biomaterials; 2011 Feb; 32(6):1657-68. PubMed ID: 21093905
[TBL] [Abstract][Full Text] [Related]
16. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Tsunoda S; Tsutsumi Y
Pharmazie; 2010 Mar; 65(3):199-201. PubMed ID: 20383940
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Biol Pharm Bull; 2016; 39(7):1201-5. PubMed ID: 27374294
[TBL] [Abstract][Full Text] [Related]
18. Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice.
Patri A; Umbreit T; Zheng J; Nagashima K; Goering P; Francke-Carroll S; Gordon E; Weaver J; Miller T; Sadrieh N; McNeil S; Stratmeyer M
J Appl Toxicol; 2009 Nov; 29(8):662-72. PubMed ID: 19626582
[TBL] [Abstract][Full Text] [Related]
19. Effects of adenovirus mediated gene transfer to mouse testis in vivo on spermatogenesis and next generation.
Kojima Y; Sasaki S; Umemoto Y; Hashimoto Y; Hayashi Y; Kohri K
J Urol; 2003 Nov; 170(5):2109-14. PubMed ID: 14532865
[TBL] [Abstract][Full Text] [Related]
20. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
De Jong WH; Hagens WI; Krystek P; Burger MC; Sips AJ; Geertsma RE
Biomaterials; 2008 Apr; 29(12):1912-9. PubMed ID: 18242692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
